Company Overview
Company Type: Private Company
Company Status: Operating Subsidiary
Website: www.precisionnanosystems.com
Number of Employees: 85
Year Founded: 2010
Total Amount Raised (CAD mm)†: 54.52
Total Rounds of Funding**:4
Latest Post-Money Valuation ($ mm) -
Latest Pre-Money Valuation ($ mm) -
† This number reflects the estimated value of the total new money raised through private placement rounds.
** This value is an estimate of the total number of funding rounds this company has received.


Business Description
Precision NanoSystems, Inc. engages in the development of lipid nanoparticle genomic medicines, including mRNA vaccines and therapeutics. Its products include Nxgen technology, that develops genetic medicine by enabling all scales through one single mixing element; instruments such as the Nanoassemblr spark, the Nanoassemblr ignite, and the Nanoassemblr blaze; the GMP system; and ionizable lipid reagents, develops GenVoy Delivery Platform comprises off-the-shelf RUO reagents such as GenVoy-ILM. It provides biopharmaceutical services that accelerate the development of lipid nanoparticle (LNP) formulations and drug products, and partnering services. The company was founded in 2010 and is based in Vancouver, Canada with an additional office in South San Francisco, California. As of June 1, 2021, Precision NanoSystems, Inc. operates as a subsidiary of Danaher Corporation.


Financial Information (Currency: CAD, in mm)
Total Revenue
 30.0
Operating Income
-
Total Assets
-
Gross Profit
-
EBITDA
-
Total Debt
-
Net Income
-
Estimated Number of Employees
 85
Net Debt
-
* Hover over data point numbers for date and source.

Key Professionals
Name
Title
Taylor, James 
Co-Founder, CEO & GM

Key Board Members
Name
Title
Geall, Andrew J.
Chairman of Scientific Advisory Board
Hansen, Carl L.G.
Member of Scientific Advisory Board
Nixon, Daniel R.
Director
Peer, Dan 
Member of Scientific Advisory Board
Slack, Frank 
Member of Scientific Advisory Board


Primary Industry Classification
Biotechnology


Primary Office Location
655 West Kent Avenue North Suite 50 | Vancouver, BC | V6P 6T7 | Canada
Phone: 888-618-0031   

Parent Company
Danaher Corporation (NYSE:DHR)

Prior Investors
5AM Venture Management, LLC (Andrew Schwab, Joseph Victor), BDC Capital Inc. (Joseph Regan), Industrial Innovation Venture Fund, Innovation, Science And Economic Development Canada, Newbury Ventures, Northview LifeSciences, Rising Tide Fund, L.P, Telegraph Hill Partners (Deval Lashkari, Robert Shepler)


Company Notes
No Company Notes exist.


Strategy Notes
No Strategy Notes exist.


Last 5 Transactions
Announced Date
Closed Date
Transaction Type
Role
Target
Buyer/Investors
Sellers
Size($mm)
Jun-01-2021
Jun-01-2021
Merger/Acquisition
Target
Precision NanoSystems, Inc.
Danaher Corporation (NYSE:DHR)
Telegraph Hill Partners,5AM Venture Management, LLC,Newbury Ventures
-
Oct-23-2020
-
Private Placement
Target
Precision NanoSystems, Inc.
Innovation, Science And Economic Development Canada

18.20
Aug-19-2019
Nov-14-2019
Private Placement
Target
Precision NanoSystems, Inc.


6.00
May-17-2018
Jun-07-2018
Private Placement
Target
Precision NanoSystems, Inc.
Telegraph Hill Partners,5AM Venture Management, LLC,Newbury Ventures Buyer Funds:Rising Tide Fund, L.P

6.00
Sep-22-2015
Sep-21-2016
Private Placement
Target
Precision NanoSystems, Inc.
Telegraph Hill Partners,5AM Venture Management, LLC

13.43
* denotes that the relationship is proprietary


Last 5 Key Developments
Date
Event Type
Headline
Sep-18-2023
Company Conference Presentations
Precision NanoSystems, Inc. Presents at American Drug Delivery & Formulation (DDF) Summit 2023, Sep-18-2023 03:40 PM
Jul-28-2023
Company Conference Presentations
Precision NanoSystems, Inc. Presents at 3rd Annual mRNA-Based Therapeutics Summit, Jul-28-2023 02:30 PM
May-31-2023
Company Conference Presentations
Precision NanoSystems, Inc. Presents at 14th Global Drug Delivery & Formulation Summit, May-31-2023
May-19-2023
Company Conference Presentations
Precision NanoSystems, Inc. Presents at American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting, May-19-2023 03:45 PM
May-07-2023
Company Conference Presentations
Precision NanoSystems, Inc. Presents at Tides USA 2023, May-07-2023 08:30 AM

M&A Advisors
Jefferies LLC


Advisors
M&A Advisors
Jefferies LLC
Private Placement Advisors
Dorsey & Whitney LLP


Last 10 Investment Research Documents
Contributor
Analyst
Date/Time
Company
Headline
Type
Pages
GlobalData

Sep 18, 2023 03:46 AM
Precision NanoSystems, Inc.
Precision NanoSystems Inc
Reports
61
GlobalData

Jul 27, 2023 07:03 AM
Precision NanoSystems, Inc.
Precision NanoSystems Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Reports
27
GlobalData

Jul 21, 2023 05:26 AM
Precision NanoSystems, Inc.
Precision NanoSystems Inc - Medical Equipment - Deals and Alliances Profile
Reports
21
GlobalData

Jun 28, 2023 04:11 AM
Precision NanoSystems, Inc.
Precision NanoSystems Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Reports
27
GlobalData

Jun 28, 2023 04:05 AM
Precision NanoSystems, Inc.
Precision NanoSystems Inc - Medical Equipment - Deals and Alliances Profile
Reports
21
GlobalData

Jun 15, 2023 06:22 AM
Precision NanoSystems, Inc.
Precision NanoSystems Inc
Reports
60
GlobalData

Mar 15, 2023 01:41 AM
Precision NanoSystems, Inc.
Precision NanoSystems Inc
Reports
60
GlobalData

Feb 13, 2023 05:28 AM
Precision NanoSystems, Inc.
Precision NanoSystems Inc - Medical Equipment - Deals and Alliances Profile
Reports
21
GlobalData

Feb 10, 2023 04:17 AM
Precision NanoSystems, Inc.
Precision NanoSystems Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Reports
27
GlobalData

Dec 15, 2022 01:49 AM
Precision NanoSystems, Inc.
Precision NanoSystems Inc
Reports
60


S&P Global Ratings Credit Ratings
No S&P Global Ratings Credit Ratings data available. 


News Headlines
No News is currently available for the selected sources.


Company Coverage
This company is not on any Coverage List.

Products
NanoAssemblr Blaze System, NanoAssemblr Spark System


Upcoming Events
Date/Time
Type
Oct-15-2023
Conferences
* Future Events are subject to change.

Key Board Members Details
Name
Title
Phone
Fax
Email
Geall, Andrew J.
Chairman of Scientific Advisory Board
888-618-0031
-

Hansen, Carl L.G.
Member of Scientific Advisory Board
888-618-0031
-

Nixon, Daniel R.
Director
888-618-0031
-
-
Peer, Dan 
Member of Scientific Advisory Board
888-618-0031
-

Slack, Frank 
Member of Scientific Advisory Board
888-618-0031
-

* denotes that the relationship is proprietary

Key Executives and Professionals Details
Name
Title
Phone
Fax
Email
Taylor, James 
Co-Founder, CEO & GM
888-618-0031
-

* denotes that the relationship is proprietary

S&P Credit Ratings and Research provided by 
No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of S&P Global Market Intelligence or its affiliates (collectively, S&P Global). The Content shall not be used for any unlawful or unauthorized purposes. S&P Global and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Global Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Global Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P GLOBAL PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Global Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P Global Market Intelligence’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P Global Market Intelligence assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P Global Market Intelligence does not act as a fiduciary or an investment advisor except where registered as such. While S&P Global Market Intelligence has obtained information from sources it believes to be reliable, S&P Global Market Intelligence does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

S&P Global keeps certain activities of its divisions separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain divisions of S&P Global may have information that is not available to other S&P Global divisions. S&P Global has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P Global Ratings does not contribute to or participate in the creation of credit scores generated by S&P Global Market Intelligence. Lowercase nomenclature is used to differentiate S&P Global Market Intelligence PD credit model scores from the credit ratings issued by S&P Global Ratings.

S&P Global may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P Global reserves the right to disseminate its opinions and analyses. S&P Global's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.capitaliq.com (subscription), and may be distributed through other means, including via S&P Global publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
Regulatory News Service data provided by 
